a synthesis of emerging evidence in ibd
Published 2 years ago • 89 plays • Length 0:30Download video MP4
Download video MP3
Similar videos
-
1:01:41
ibd: identified uncertainties in optimising biologic & small molecule medicines –the latest evidence
-
8:45
what matters most in ibd? part 4/7
-
21:14
when and how to use immunomodulators and biologics in ibd
-
10:03
how integrative therapy can help you manage your crohn's and colitis
-
26:05
pediatric inflammatory bowel disease: updates for primary care providers
-
20:04
is there an optimal approach to prevent recurrence in post-operative crohn's disease
-
12:48
ibd clinical update: new and emerging targeted therapies
-
18:23
selection and use of the new and coming therapies for ibd? who? when? how?
-
21:36
keynote: evolution of disease management in ibd
-
1:00:04
new advances in nutritional management of pediatrics crohn’s disease
-
15:10
new crohn's & colitis medications and ibd treatments on the horizon
-
29:01
advances in ibd treatment: expert q&a
-
20:26
what are the roles of environmental factors in the pathogenesis of ibd
-
8:00
new model of care for inflammatory bowel disease video – brigham and women’s hospital
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
41:15
targeting ibd: hitting the mark in today’s treatment landscape
-
24:46
case discussion: marijuana in ibd: who should get it? how should we help?
-
16:40
inflammatory pathways targeted in the pathophysiology of ibd: clinical trial results
-
13:54
aminosalicylates in ibd: new data on an old therapy